CorMedix (CRMD)
About
Business overview of CorMedix (CRMD)
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.
Key Insights
Critical company metrics and information
Share Price
$10.81Market Cap
$655.92 MillionTotal Outstanding Shares
60.68 Million SharesTotal Employees
82Dividend
No dividendIPO Date
May 13, 2010SIC Description
Pharmaceutical PreparationsPrimary Exchange
NASDAQType
Common StockPhone Number
908-517-9500Address
300 connell drive, Berkeley heights, NJ, 07922Homepage
https://www.cormedix.com
Historical Stock Splits
If you bought 1 share of CRMD before March 26, 2019, you'd have 0.20 shares today.
| Execution Date | Split Amount |
|---|---|
| March 26, 2019 | 1-for-5 (Reverse Split) |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $-18.11 Million |
| Net Cash Flow From Operating Activities, Continuing | $-55.75 Million |
| Net Cash Flow From Financing Activities | $15.50 Million |
| Net Cash Flow From Investing Activities | $22.13 Million |
| Exchange Gains/Losses | $1,945.00 |
| Net Cash Flow From Investing Activities, Continuing | $22.13 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Parent | $-46.15 Million |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $-0.81 |
| Basic Average Shares | $118.57 Million |
| Operating Expenses | $61.21 Million |
| Diluted Average Shares | $118.57 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Current Liabilities | $18.48 Million |
| Noncurrent Assets | $4.43 Million |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Accounts Payable | $1.34 Million |
| Liabilities And Equity | $77.59 Million |
| Inventory | $6.65 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2025 Financhle. All Rights Reserved.